4D Molecular Therapeutics, Inc.

FDMT· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$14.68+6.69%

2026-09-17

Financials

Valuation Metrics

4D Molecular Therapeutics, Inc.'s Market Cap is $767M. At end of 2025 it was $434M. Ranked #2611 of 3,121 in US market (top 84%), #1106 of 1,463 on NASDAQ (top 76%), #202 of 266 in Pharmaceuticals, Biotechnology & Life Sciences (top 76%) by Market Cap.

Investment Metrics(as of 2026-09-18)

Metric	Value	Rank
Size
Market Cap	$767M	US#2,611/3,121 Sec#202/266
Revenue	$92M	US#2,719/3,121 Sec#129/266
Net Income	$-179M	US—/3,121 Sec—/266
Total Assets	$493M	US#2,775/3,121 Sec#167/266
Net Assets	$408M	US#2,371/3,121 Sec#135/266
Value
P/B	1.88x	US#1,157/3,121 Sec#42/266
P/S	8.34x	US#2,623/3,121 Sec#104/266
FCF Yield	-20.41%	US—/3,121 Sec—/266
Profitability
ROE	-43.95%	US#2,653/3,121 Sec#144/266
ROA	-36.37%	US#2,927/3,121 Sec#178/266
Op. Margin	-214.24%	US#2,777/3,121 Sec#139/266
Revenue Growth	278712.12%	US#1/3,121 Sec#1/266
Financial Health
Debt Ratio	20.84%	US#238/3,121 Sec#80/266
Total Debt	$39M	US#2,652/3,121 Sec#163/266
FCF	$-157M	US#2,727/3,121 Sec#181/266
Cash	$70M	US#2,423/3,121 Sec#203/266
Current Ratio	8.03x	US#318/3,121 Sec#98/266
Performance
1Y Return	120.42%	US#156/3,121 Sec#54/266
1M Return	-0.27%	US#982/3,121 Sec#95/266
From 52W High	-13.29%	US#991/3,121 Sec#67/266
1Y MDD	-41.40%	US#2,072/3,121 Sec#144/266
Trading
Volume	923,881 shares	US#1,461/3,121 Sec#156/266
Trading Value	$13M	US#2,161/3,121 Sec#175/266
Per Share
EPS	$-3.43	US—/3,121 Sec—/266
BPS	$7.80	US#2,020/3,121 Sec#90/266